Holen Sie sich die Stockscreener-App
14.12
1.88%
-0.27
Handel nachbörslich:
14.14
0.02
+0.14%
Schlusskurs vom Vortag:
$14.39
Offen:
$14.47
24-Stunden-Volumen:
6.57M
Relative Volume:
1.17
Marktkapitalisierung:
$7.01B
Einnahmen:
$4.45B
Nettoeinkommen (Verlust:
$205.00M
KGV:
35.30
EPS:
0.4
Netto-Cashflow:
$372.00M
1W Leistung:
-5.99%
1M Leistung:
-1.19%
6M Leistung:
+13.23%
1J Leistung:
+9.46%
1-Tages-Spanne:
$14.06
$14.47
1-Wochen-Bereich:
$14.06
$15.14
52-Wochen-Spanne:
$8.02
$15.78
Elanco Animal Health Inc Stock (ELAN) Company Profile
Firmenname
Elanco Animal Health Inc
Sektor
Telefon
877-352-6261
Adresse
2500 INNOVATION WAY, GREENFIELD
Vergleichen Sie ELAN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
14.12 | 7.15B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
148.81 | 67.23B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
9.64 | 44.07B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.60 | 45.23B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.83 | 18.97B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
136.76 | 13.28B | 2.41B | 305.80M | 492.20M | 2.95 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-17 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-09-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-19 | Eingeleitet | Jefferies | Buy |
| 2023-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-04-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Sell |
| 2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-06-15 | Hochstufung | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Eingeleitet | Stifel | Buy |
| 2021-03-22 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Herabstufung | Argus | Buy → Hold |
| 2020-11-09 | Herabstufung | Barclays | Overweight → Underweight |
| 2020-08-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-08-04 | Fortgesetzt | Goldman | Buy |
| 2020-07-27 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Eingeleitet | Barclays | Overweight |
| 2019-08-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-03-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Eingeleitet | William Blair | Mkt Perform |
| 2019-01-23 | Eingeleitet | UBS | Sell |
| 2019-01-15 | Eingeleitet | Argus | Buy |
| 2018-10-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
Unexpected Trends Reshaping the Veterinary Oncology U.S. - openPR.com
Sector Rotation Brings Elanco Animal Health Incorporated Into FocusMulti-Bagger Potential Stock Forecast Tools Released - beatles.ru
Animal Growth Promoter Market Size and Share Forecast Outlook - openPR.com
Fish Vaccine Market Generated Opportunities, Future Scope - openPR.com
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Bought by Victory Capital Management Inc. - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Allianz Asset Management GmbH Sells 317,192 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
European Commission approves Zenrelia - DVM360
How does Elanco Animal Health Incorporated generate profit in a changing economyMaximize returns with smart investment plans - jammulinksnews.com
Wyckoff Accumulation Phase Possible in Elanco Animal Health IncorporatedEntry Points For Growing Stocks Identified by Models - metal.it
Dogs Vaccines Market to Witness Comprehensive Growth by 2032 | - openPR.com
What are the latest earnings results for Elanco Animal Health IncorporatedLightning-fast capital gains - jammulinksnews.com
Elanco Animal Health Incorporated Company’s Quarterly Earnings Growth: What the Numbers SayMinimized Risk Trading Plan - metal.it
Universal Beteiligungs und Servicegesellschaft mbH Invests $5.70 Million in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Purchased by Envestnet Asset Management Inc. - MarketBeat
Does Elanco Animal Health Incorporated stock perform well during market downturnsBreakthrough profit margins - jammulinksnews.com
What institutional investors are buying Elanco Animal Health Incorporated stockExplosive trading growth - jammulinksnews.com
Equitable Trust Co. Purchases 24,129 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Animal Health (NYSE:ELAN) Price Target Raised to $18.00 - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Bought by Private Management Group Inc. - MarketBeat
Why Elanco (ELAN) Stock Is Trading Up Today - TradingView
Elanco Animal Health Incorporated Stock Analysis and ForecastLightning-fast capital gains - PrintWeekIndia
What drives Elanco Animal Health Incorporated stock priceLightning-fast growth - PrintWeekIndia
Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs - The Malaysian Reserve
Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs | ELAN Stock News - GuruFocus
EU Approval Boosts Elanco (ELAN) with Zenrelia Milestone | ELAN Stock News - GuruFocus
What analysts say about Elanco Animal Health Incorporated stockDynamic portfolio growth - PrintWeekIndia
ELAN vs. USPH: Which Stock Is the Better Value Option? - Yahoo Finance
Aquatic Veterinary Market Set to Witness Significant Growth - openPR.com
Jennison Associates LLC Sells 329,115 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Animal Health (ELAN): UBS Maintains Buy Rating, Raises Pr - GuruFocus
Autogenous Vaccine for Aquaculture Market Generated - openPR.com
ELANCO SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Elanco Animal Health Inc. (NYSE:ELAN) And Encourages Long-Term Investors to Contact the FirmELAN - ACCESS Newswire
Is Elanco Animal Health Incorporated a good long term investmentHigh-profit trading signals - jammulinksnews.com
Are Medical Stocks Lagging Encompass Health (EHC) This Year? - Yahoo Finance
Veterinary Oncology Market Growth in Future Scope 2025-2032 | - openPR.com
Veterinary DermatologyCompany Evaluation Report 2025 | Zoetis, Elanco, and Boehringer Ingelheim Dominate with Global Reach, Innovative Portfolios, and Strategic Expansion - Yahoo Finance
FY2025 Earnings Forecast for ELAN Issued By Leerink Partnrs - MarketBeat
Leerink Partnrs Has Strong Estimate for ELAN FY2027 Earnings - Defense World
Xponance Inc. Has $256,000 Stock Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
M&T Bank Corp Sells 1,445 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
DDD Partners LLC Has $15.68 Million Stock Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Animal Health (NYSE:ELAN) Raised to “Outperform” at Leerink Partners - Defense World
Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.50%
1.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):